MorphoSys, a company whose research has yielded programs placed with big pharmaceutical companies and upstart biotechs, is stopping all preclinical work to focus on cancer, particularly a late-stage drug candidate it acquired in a…
Continue Reading
As a health economist, researcher in evidence-based medicine, and consultant to biopharma executives, I am no stranger to data. We all want more of it, to make sense of it, and to use it…
Continue Reading
While 73% of benefits leaders believe their companies have increased mental health support, only half of managers and supervisors agree, a new survey shows. About 40% of employees don’t believe or are unsure if…
Continue Reading
More and more healthcare leaders are beginning to treat violence as a public health issue as gun deaths and other forms of assault continue to impact communities across the country. One large health system…
Continue Reading
A California lawmaker recently introduced legislation designed to keep the state’s small and rural hospitals from closing as they work to meet seismic safety compliance requirements.
State law has set a timeline for hospitals to…
At a time when children and families are increasingly in need of mental health support, Evernorth Health Group said it will offer behavioral health provider Brightline’s services to its employer clients.
The two companies announced…
![Travel Nurses: Risk Management Insights [Sponsored]](https://www.mediformatica.com/wp-content/uploads/2023/03/travel-nurses-risk-management-insights-sponsored.jpg)
The healthcare sector is struggling with staffing shortages. Travel nurses help bridge the gaps, enabling healthcare facilities to maintain service levels. While the use of travel nurses has been necessary, it has led to…
Continue Reading
Eli Lilly is cutting insulin prices, and this time it’s for real.
Months after a Twitter account posing as the drugmaker went viral with a tweet stating, “insulin is free now,” the company on Wednesday…
MedCity News’ Pivot podcast is back with another episode in its Season 1, which focused on chronic disease management. This time we are talking with Steve Driver with Advocate Aurora Health. Driver is an…
Continue Reading
Friedrich’s ataxia, an ultra-rare disease that causes progressively worsening muscle function that ultimately leads to death, now has its first FDA-approved therapy. The regulator has given the green light to a Reata Pharmaceuticals drug…
Continue Reading
